Join Physitrack PLC's Q4 2024 Interim Report Webcast Conference: A Glimpse into the Future of Digital Healthcare

Physitrack PLC (PTRK), a global digital healthcare provider, is set to publish its Q4 2024 interim report on February 28, 2025, followed by a webcast conference at 15.00 CET. This event presents an excellent opportunity for investors, analysts, and industry professionals to gain insights into the company's financial performance, strategic initiatives, and future outlook.

Physitrack PLC's Q4 2024 interim report will provide a comprehensive overview of the company's financial performance, highlighting key metrics such as revenue growth, EBITDA margins, and adjusted earnings per share. The webcast conference, featuring CEO Henrik Molin and CFO Charlotte Goodwin, will offer a deeper dive into the company's results, as well as an opportunity for participants to ask questions through Zoom's Q&A function.



The company's Lifecare division, focused on physiotherapy and musculoskeletal care providers, has demonstrated remarkable and consistent profitability, particularly in Physitrack platform subscription sales to the MSK rehabilitation segment. This division has firmly positioned itself as a leading provider of software for injury prevention and recovery solutions, ensuring its ongoing relevance in the evolving healthcare landscape.

In the Wellness division, innovation, talent acquisition, and successful integration of acquired businesses have been key drivers of early growth. Despite challenges arising from delays in the international rollout of Champion Health's software, significant progress has been made with Swedish and German market entries in October, and long-term prospects for Champion Health remain strong.

Looking ahead, the Lifecare division continues to enhance its market share by providing market-leading solutions that address emerging healthcare needs. Meanwhile, with international Champion Health versions launched at the end of October, the Wellness division is set to be well-positioned for rapid expansion with new products and markets that empower health and wellbeing, allowing the company to capitalize on the rising demand for digital health solutions.



Investors, analysts, and industry professionals are encouraged to register for the webcast conference and participate in the Q&A session to gain valuable insights into Physitrack PLC's financial performance, strategic initiatives, and future outlook. This event is an excellent opportunity to engage with the company's leadership team and learn more about the exciting developments in the digital healthcare sector.

In conclusion, Physitrack PLC's Q4 2024 interim report webcast conference is a must-attend event for anyone interested in the digital healthcare sector. The company's strong financial performance, innovative solutions, and strategic initiatives make it an attractive investment opportunity. By participating in the webcast conference and engaging with the company's leadership team, investors can gain a deeper understanding of Physitrack PLC's prospects and make informed decisions about their investments in the digital healthcare sector.